What is a stock summary page? Click here for an overview.
Business Description
Milestone Pharmaceuticals Inc
NAICS : 325412
SIC : 3741
ISIN : CA59935V1076
Description
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.27 | |||||
| Equity-to-Asset | 0.17 | |||||
| Debt-to-Equity | 4.17 | |||||
| Debt-to-EBITDA | -1.45 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 16 | |||||
| 3-Year EPS without NRI Growth Rate | 13.1 | |||||
| 3-Year FCF Growth Rate | 16.4 | |||||
| 3-Year Book Growth Rate | -59.7 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 36.98 | |||||
| 9-Day RSI | 44.15 | |||||
| 14-Day RSI | 46.28 | |||||
| 3-1 Month Momentum % | 13.33 | |||||
| 6-1 Month Momentum % | 31.61 | |||||
| 12-1 Month Momentum % | 30.77 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 9.1 | |||||
| Quick Ratio | 9.1 | |||||
| Cash Ratio | 8.58 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -21.3 | |||||
| Shareholder Yield % | -29.5 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -164.98 | |||||
| ROA % | -49.59 | |||||
| ROIC % | -1052.02 | |||||
| 3-Year ROIIC % | 47.67 | |||||
| ROC (Joel Greenblatt) % | -2020.13 | |||||
| ROCE % | -48.72 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 8.18 | |||||
| Price-to-Tangible-Book | 8.18 | |||||
| EV-to-EBIT | -2.25 | |||||
| EV-to-EBITDA | -2.26 | |||||
| EV-to-Forward-EBITDA | -1.38 | |||||
| EV-to-Forward-Revenue | 17.29 | |||||
| EV-to-FCF | -3.09 | |||||
| Price-to-Net-Current-Asset-Value | 9.3 | |||||
| Price-to-Net-Cash | 14.62 | |||||
| Earnings Yield (Greenblatt) % | -44.44 | |||||
| FCF Yield % | -26.42 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:MIST
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Milestone Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.68 | ||
| Beta | -0.01 | ||
| 3-Year Sharpe Ratio | -0.22 | ||
| 3-Year Sortino Ratio | -0.3 | ||
| Volatility % | 55.09 | ||
| 14-Day RSI | 46.28 | ||
| 14-Day ATR ($) | 0.201058 | ||
| 20-Day SMA ($) | 1.9125 | ||
| 12-1 Month Momentum % | 30.77 | ||
| 52-Week Range ($) | 1.12 - 2.75 | ||
| Shares Outstanding (Mil) | 53.35 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Milestone Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Milestone Pharmaceuticals Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Milestone Pharmaceuticals Inc Frequently Asked Questions
What is Milestone Pharmaceuticals Inc(MIST)'s stock price today?
The current price of MIST is $2.05. The 52 week high of MIST is $2.75 and 52 week low is $1.12.
When is next earnings date of Milestone Pharmaceuticals Inc(MIST)?
The next earnings date of Milestone Pharmaceuticals Inc(MIST) is 2025-05-13 Est..
Does Milestone Pharmaceuticals Inc(MIST) pay dividends? If so, how much?
Milestone Pharmaceuticals Inc(MIST) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers